Welcome to our dedicated page for Medical Prop SEC filings (Ticker: MPW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Medical Properties Trust, Inc. (NYSE: MPW) SEC filings page provides access to the company’s official regulatory disclosures as a self-advised real estate investment trust focused on net-leased hospital facilities. Formed in 2003 and incorporated in Maryland, Medical Properties Trust files reports and current disclosures with the U.S. Securities and Exchange Commission in connection with its common stock listed on the New York Stock Exchange under the symbol MPW.
Through this page, users can review key filings such as Form 10-K annual reports, which typically include detailed information on the company’s healthcare real estate portfolio, general acute, behavioral health and post-acute facilities, geographic exposure across the United States and international markets, capital structure, risk factors and management’s discussion and analysis. Form 10-Q quarterly reports provide interim updates on revenues from rent billed, straight-line rent, income from financing leases, interest and other income, as well as expenses, impairment charges, joint venture performance and balance sheet changes.
Investors can also examine Form 8-K current reports, where Medical Properties Trust discloses material events such as quarterly earnings releases, approval of a stock repurchase program, and other significant corporate actions. For example, Form 8-K filings in 2025 reference press releases announcing financial results for specific quarters and the authorization of a common stock repurchase program. In addition, filings may include exhibits with supplemental information packages and investor presentations.
Alongside traditional document access, this page highlights AI-powered tools that summarize lengthy filings, explain complex sections and surface important items such as changes in rent collections, impairment charges, financing transactions and capital allocation decisions. Users can quickly identify relevant sections of 10-Ks, 10-Qs and 8-Ks, and track how Medical Properties Trust reports on its hospital real estate portfolio, debt profile and shareholder-related actions over time.
Medical Properties Trust Inc. senior vice president and senior advisor to the CEO, Larry H. Portal, reported an automatic share withholding tied to equity compensation. On January 9, 2026, 11,067 shares of common stock were withheld at $5.04 per share to cover tax obligations arising from the vesting of restricted stock. The filing states this withholding "does not constitute a sale transaction," meaning it was not an open-market sale. After this adjustment, Portal beneficially owned 470,624 shares of Medical Properties Trust common stock in direct ownership.
Medical Properties Trust insider reports tax withholding on vested stock. Senior VP, Controller & CAO James Kevin Hanna reported that on January 9, 2026, 9,274 shares of Medical Properties Trust common stock were withheld upon vesting of restricted stock to cover tax obligations at a reference price of $5.04 per share. The filing specifies this is not a sale transaction. After this withholding, Hanna directly holds 434,294 shares of the company’s common stock.
Medical Properties Trust executive Steven R. Hamner, Executive Vice President and CFO, reported equity award activity in the company’s common stock. On January 8, 2026, he was granted 509,124 shares tied to performance goals for debt reduction and cash revenue growth from January 1, 2026 through December 31, 2028, and 549,854 restricted shares that will vest in equal installments at the beginning of each of 12 calendar quarters starting April 1, 2026. On January 9, 2026, 67,265 shares were withheld at $5.04 per share to satisfy tax obligations upon vesting of restricted stock, which is described as not constituting a sale. After these transactions, Hamner directly beneficially owned 3,889,568 shares of Medical Properties Trust common stock.
Medical Properties Trust Chairman, President & CEO Edward K. Aldag Jr. reported several stock-related transactions. On January 8, 2026, he was granted 1,018,247 shares of common stock that will be earned only if specific performance thresholds for reducing overall debt and growing cash revenue are met from January 1, 2026 through December 31, 2028, with a chance to earn up to one third based on 2026 results and further adjustment based on total shareholder return. The same day he also received 1,099,707 shares of common stock that vest in equal installments at the beginning of each of 12 calendar quarters starting April 1, 2026. On January 9, 2026, 188,951 shares were withheld at $5.04 per share to cover tax obligations upon vesting of restricted stock, which is not treated as a sale. After these transactions, he directly beneficially owns 6,904,641 shares of common stock.
Medical Properties Trust Inc. received an updated large-shareholder disclosure from investor He Zhengxu on a Schedule 13G/A (Amendment No. 2). He reports beneficial ownership of 41,662,706 shares of the company’s common stock, representing 6.9% of the outstanding class as of the event date 12/31/2025. He, a United States citizen, has sole power to vote and dispose of all these shares, with no shared voting or dispositive power reported. The filing states that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Medical Properties Trust.
Medical Properties Trust Inc. reported that its SVP of Operations sold 2,000 shares of common stock on 12/15/2025 at a price of $5 per share.
After this sale, the officer directly owned 395,182 shares of Medical Properties Trust common stock. No derivative securities transactions were reported in the derivative securities table.
Medical Properties Trust, Inc. (MPW) director W. Zachary Riddle reported a sale of company stock. On 11/19/2025, he sold 59,000 shares of common stock at a weighted average price of $5.02 per share, with individual trade prices ranging from $4.99 to $5.05. After this transaction, he beneficially owned 157,100 shares of MPW common stock in direct ownership. The trades were executed in multiple transactions, and full trade details are available upon request as noted in the filing.
Medical Properties Trust (MPW) insider activity: The company’s Chairman, President and CEO, who is also a director, reported gifting 194,600 shares of common stock on 11/18/2025. The transaction is coded as a gift at a price of $0.00, meaning no sale proceeds were received. Following this charitable transfer, the reporting person directly owns 5,079,412 shares of Medical Properties Trust common stock.
Medical Properties Trust (MPW) filed a Form 144 notice for a planned sale of 59,000 shares of common stock through Charles Schwab on 11/19/2025, with an aggregate market value of $300,900. The filing states that 601,500,000 shares of common stock were outstanding and that the 59,000 shares to be sold were originally acquired from the issuer on 05/02/2011 as compensation stock grants, with payment dated 05/03/2011.
State Street Corporation filed a Schedule 13G reporting a passive stake in Medical Properties Trust (MPW). The firm reported beneficial ownership of 26,958,391 shares, representing 4.5% of the common stock as of the event date 09/30/2025.
State Street reported shared voting power over 22,164,338 shares and shared dispositive power over 26,958,391 shares, with no sole voting or dispositive power. It certified the holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of MPW. The filing lists multiple asset management subsidiaries and identifies State Street as a holding company (HC).